RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Cary, NC · Chapel Hill, NC · +119 more sites
3 recruiting psoriasis studies with a site in Wilmington, NC.
Sponsor: Bristol-Myers Squibb
Cary, NC · Chapel Hill, NC · +119 more sites
Sponsor: Vanda Pharmaceuticals
Wilmington, NC · +9 more sites
Sponsor: AbbVie
Morrisville, NC · Wilmington, NC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.